Global Herpes Zoster Infection Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 150496
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 116
  • list Pharmaceuticals and Healthcare

Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many years after the occurrence of chicken pox infection and is as reactive as Herpes Zoster.

Scope of the Report:

This report studies the Herpes Zoster Infection Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Herpes Zoster Infection Treatment market by product type and applications/end industries.

Chickenpox is caused by initial infection of VZV virus, after chicken pox is resolved the virus remains inactive in the nerve cells. The virus gets reactive travels to the nerve end producing blisters. The rash increases within two or three weeks. Herpes zoster appear as blisters on one side of the body usually on neck, face or torso. Some symptoms beyond pain and rashes are fever, headache, fatigue and muscles weakness. Person who had chicken pox is at risk of herpes zoster. The person with the herpes zoster can pass on the virus to someone else who never had chicken pox, but the person will develop chicken pox and not herpes zoster.

Herpes zoster is prevalent in older adults usually between 60 to 80 years as they have weak immune system. People undergoing radiation therapy or chemotherapy weakens the immune system and are more prone to herpes zoster disease. The diagnosis of the herpes zoster is done by laboratory test to detect the VZV antibody in the blood. After the diagnosis of the herpes zoster medication is given for the treatment which include oral medicines, topical and vaccines.  Antihistamines, numbing creams, gels, or patches are given to reduce the pain. Vaccines are mostly given to the older people who have a higher risk of getting the herpes zoster

The global Herpes Zoster Infection Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Herpes Zoster Infection Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Valeant Pharmaceuticals

Camber Pharmaceuticals

Novartis

Teva Pharmaceutical

Abbott

Merck

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oral

Topical

Parental

Market Segment by Applications, can be divided into

Clinics

Hospitals

Diagnostic centers

Home Care

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Herpes Zoster Infection Treatment Market Overview

1.1 Product Overview and Scope of Herpes Zoster Infection Treatment

1.2 Classification of Herpes Zoster Infection Treatment by Types

1.2.1 Global Herpes Zoster Infection Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Herpes Zoster Infection Treatment Revenue Market Share by Types in 2017

1.2.3 Oral

1.2.4 Topical

1.2.5 Parental

1.3 Global Herpes Zoster Infection Treatment Market by Application

1.3.1 Global Herpes Zoster Infection Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Clinics

1.3.3 Hospitals

1.3.4 Diagnostic centers

1.3.5 Home Care

1.4 Global Herpes Zoster Infection Treatment Market by Regions

1.4.1 Global Herpes Zoster Infection Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Herpes Zoster Infection Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Herpes Zoster Infection Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Valeant Pharmaceuticals

2.1.1 Business Overview

2.1.2 Herpes Zoster Infection Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Valeant Pharmaceuticals Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Camber Pharmaceuticals

2.2.1 Business Overview

2.2.2 Herpes Zoster Infection Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Camber Pharmaceuticals Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Herpes Zoster Infection Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Teva Pharmaceutical

2.4.1 Business Overview

2.4.2 Herpes Zoster Infection Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Teva Pharmaceutical Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 Abbott

2.5.1 Business Overview

2.5.2 Herpes Zoster Infection Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Abbott Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Merck

2.6.1 Business Overview

2.6.2 Herpes Zoster Infection Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Merck Herpes Zoster Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Herpes Zoster Infection Treatment Market Competition, by Players

3.1 Global Herpes Zoster Infection Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Herpes Zoster Infection Treatment Players Market Share

3.2.2 Top 10 Herpes Zoster Infection Treatment Players Market Share

3.3 Market Competition Trend

4 Global Herpes Zoster Infection Treatment Market Size by Regions

4.1 Global Herpes Zoster Infection Treatment Revenue and Market Share by Regions

4.2 North America Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

5 North America Herpes Zoster Infection Treatment Revenue by Countries

5.1 North America Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)

5.2 USA Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

6 Europe Herpes Zoster Infection Treatment Revenue by Countries

6.1 Europe Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)

6.2 Germany Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

6.4 France Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Herpes Zoster Infection Treatment Revenue by Countries

7.1 Asia-Pacific Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)

7.2 China Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

7.5 India Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

8 South America Herpes Zoster Infection Treatment Revenue by Countries

8.1 South America Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)

8.2 Brazil Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Herpes Zoster Infection Treatment by Countries

9.1 Middle East and Africa Herpes Zoster Infection Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Herpes Zoster Infection Treatment Revenue and Growth Rate (2013-2018)

10 Global Herpes Zoster Infection Treatment Market Segment by Type

10.1 Global Herpes Zoster Infection Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Herpes Zoster Infection Treatment Market Forecast by Type (2018-2023)

10.3 Oral Revenue Growth Rate (2013-2023)

10.4 Topical Revenue Growth Rate (2013-2023)

10.5 Parental Revenue Growth Rate (2013-2023)

11 Global Herpes Zoster Infection Treatment Market Segment by Application

11.1 Global Herpes Zoster Infection Treatment Revenue Market Share by Application (2013-2018)

11.2 Herpes Zoster Infection Treatment Market Forecast by Application (2018-2023)

11.3 Clinics Revenue Growth (2013-2018)

11.4 Hospitals Revenue Growth (2013-2018)

11.5 Diagnostic centers Revenue Growth (2013-2018)

11.6 Home Care Revenue Growth (2013-2018)

12 Global Herpes Zoster Infection Treatment Market Size Forecast (2018-2023)

12.1 Global Herpes Zoster Infection Treatment Market Size Forecast (2018-2023)

12.2 Global Herpes Zoster Infection Treatment Market Forecast by Regions (2018-2023)

12.3 North America Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)

12.6 South America Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Herpes Zoster Infection Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Herpes Zoster Infection Treatment Picture

Table Product Specifications of Herpes Zoster Infection Treatment

Table Global Herpes Zoster Infection Treatment and Revenu

Please fill the form below, to recieve the report sample


+1